General form of registration statement for all companies including face-amount certificate companies

Summary of significant accounting policies (Details Narrative)

v3.7.0.1
Summary of significant accounting policies (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended 11 Months Ended 12 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Mar. 31, 2017
Mar. 31, 2015
Jun. 30, 2016
Mar. 31, 2016
Jun. 30, 2015
Jun. 30, 2014
May 12, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Revenue     $ 14,500            
Cash and cash equivalents $ 4,155,444 $ 4,329,496 $ 9,425,699 $ 687,739 $ 4,155,444 $ 2,730,105 $ 4,329,496 $ 489,640
Grant income $ 20,500 $ 29,999   $ 137,500 $ 254,834 $ 264,333 $ 167,499    
Patents [Member]                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Useful lives     15 years   15 years        
Minimum [Member]                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Estimated useful lives         P3Y        
Maximum [Member]                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Estimated useful lives         P10Y        
Restricted Stock [Member]                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Share outstanding 1,361,055 546,886 2,144,055 623,855 1,361,055 1,353,055 546,886